International Biotechnology Trust plc
IBT.L · LSE
8/31/2025 | 2/28/2025 | 8/31/2024 | 2/29/2024 | |
|---|---|---|---|---|
| Revenue | £6 | £13 | £10 | £32 |
| % Growth | -52.8% | 21.3% | -67.7% | – |
| Cost of Goods Sold | £2 | £3 | -£0 | £5 |
| Gross Profit | £2 | £13 | £11 | £27 |
| % Margin | 28.2% | 100% | 104.4% | 83.6% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £3 | £0 | £3 |
| SG&A Expenses | £0 | £3 | £0 | £3 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Expenses | £0 | £3 | £0 | £3 |
| Operating Income | -£9 | £9 | £11 | £29 |
| % Margin | -157.7% | 74.2% | 100.5% | 89.6% |
| Other Income/Exp. Net | £1 | -£2 | £0 | -£1 |
| Pre-Tax Income | -£8 | £7 | £11 | £28 |
| Tax Expense | £0 | £0 | £0 | £0 |
| Net Income | -£8 | £7 | £11 | £28 |
| % Margin | -136.9% | 55.4% | 100.7% | 87.4% |
| EPS | -0.23 | 0.19 | 0.29 | 0.73 |
| % Growth | -221.1% | -34.5% | -60.3% | – |
| EPS Diluted | -0.23 | 0.19 | 0.29 | 0.73 |
| Weighted Avg Shares Out | 36 | 36 | 37 | 39 |
| Weighted Avg Shares Out Dil | 36 | 36 | 37 | 39 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | -£1 | £1 |
| Interest Expense | £0 | £1 | £0 | £0 |
| Depreciation & Amortization | £0 | -£9 | £0 | -£29 |
| EBITDA | -£9 | £0 | £11 | -£1 |
| % Margin | -157.7% | 0% | 100.5% | -1.9% |